Drug Trial Radar · NCT07741526
Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)
Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
33
Actual
Start
Oct 14, 2025
Primary completion
Apr 30, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- Arctic TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Blueskin AS
- First posted
- Aug 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 84 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to measure safety, tolerability and biomarker-based efficacy of NPI-001 (AT-001) in Subjects with MCI or Alzheimer's Disease (AD). In the study participants receive increasing dose of active treatment (250mg vs 500mg vs 750mg) or matched placebo in the form of tablets BID.
Conditions
- Alzheimer´s Disease
Interventions
NPI-001Drug
NPI-001 tablets administered orally BID at escalating doses of 250 mg, 500 mg, and 750 mg for period of 12 months
PlaceboDrug
Placebo tablets administered orally BID at escalating doses of 250 mg, 500 mg, and 750 mg for period of 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment -Emergent Adverse EventsTime frame: Through study completion, approximately up to 14 months
- Safety labs results within normal rangeTime frame: Through study completion, approximately up to 14 months
- Assessment of ARIA H and ARIA E in the brain with MRI imagingTime frame: Through study completion, approximately up to 14 months
Locations
4 sites in 2 countries. Site status is shown where the registry gives one.
Sanos Clinic Gandrup
Gandrup, Denmark
Sanos Clinic Herlev
Herlev, Denmark
Sanos Clinic Vejle
Vejle, Denmark
Landspitali University Hospital
Reykjavik, Iceland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.